Key Shareholders
| Shareholders over 5% and Key Strategic Investors | Number | % |
|---|---|---|
| dievini Hopp BioTech holding GmbH & Co KG | 16,316,742 | 16.5% |
| Biotechnology Value Fund (BVF) Inc. | 14,571,236 | 14.8% |
| Varuma AG | 11,999,999 | 12.1% |
| Affiris AG | 6,578,100 | 6.7% |
| Avidity Partners Management LP | 4,398,371 | 4.5% |
| Eli Lilly and Company | 3,615,328 | 3.7% |
| FCPB Affi GmbH | 2,356,342 | 2.4% |
| Santo Venture Capital GmbH | 2,227,602 | 2.3% |
| Redmile | 2,000,000 | 2.0% |
| Blackrock | 1,977,475 | 2.0% |
| Executive officers and directors | 4,791,914 | 4.8% |